MC
LLY icon

Mathes Company’s Eli Lilly LLY Stock Holding History

Mathes Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$926K Buy
772
+190
+33% +$194K 0.29% 59
2026
Q1 		$535K Hold
582
– – 0.2% 79
2025
Q4 		$625K Hold
582
– – 0.22% 68
2025
Q3 		$444K Buy
582
+147
+34% +$109K 0.16% 90
2025
Q2 		$339K Sell
435
-510
-54% -$396K 0.13% 104
2025
Q1 		$780K Buy
945
+385
+69% +$320K 0.32% 60
2024
Q4 		$432K Buy
+560
New +$464K 0.16% 91

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mathes Company's LLY Position: Q2 2026 in Review

Mathes Company increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $194K and bringing the position to 772 shares worth $926K. The position accounts for 0.29% of the portfolio, ranked #59.

Mathes Company first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mathes Company held 772 shares of Eli Lilly worth $926K as of Q2 2026.
  • Mathes Company bought 190 Eli Lilly shares in Q2 2026, an estimated $194K.
  • Eli Lilly made up 0.29% of Mathes Company's portfolio in Q2 2026, its #59 holding.
  • Mathes Company first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.